• BioStem added VENDAJE and VENDAJE AC to existing Vizient, Premier GPO contracts, opening hospital purchasing access effective immediately.
• Update marks the first GPO contract coverage for the two placental-derived wound-care allografts.
• Broader reach into Vizient’s 5,000-plus hospitals, Premier’s 4,000-plus hospitals through established contracting channels.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biostem Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609040700PRIMZONEFULLFEED9821573) on September 04, 2026, and is solely responsible for the information contained therein.